搜索临床试验以:贝伐单抗和曲贝替定
总计272925个结果
-
BiosencyRennes University Hospital; Slb Pharma; Air de Bretagne; Centre Hospitalier Bretagne Atlantique; Centre... 和其他合作者招聘中
-
Mayo ClinicNational Cancer Institute (NCI)招聘中III 期肝内胆管癌 AJCC v8 | 不可切除的肝细胞癌 | III 期肝细胞癌 AJCC v8 | IV 期肝细胞癌 AJCC v8 | IV 期肝内胆管癌 AJCC v8 | 不可切除的肝内胆管癌美国
-
Shahid Beheshti University of Medical Sciences未知
-
Pfizer招聘中
-
Shahid Beheshti University of Medical Sciences主动,不招人
-
Children's Hospital of Fudan UniversityNational Key Research and Development Program of China完全的
-
Sussex Community NHS Foundation TrustUniversity of Cambridge; National Institute for Health Research, United Kingdom; Brighton & Sussex... 和其他合作者招聘中
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)完全的IV 期结直肠癌 AJCC v7 | IVA 期结直肠癌 AJCC v7 | IVB 期结直肠癌 AJCC v7 | 结直肠腺癌 | RAS 野生型美国
-
National Taiwan University Hospital完全的
-
National Cancer Institute (NCI)尚未招聘复发性卵巢高级别浆液性腺癌 | 复发性铂耐药卵巢癌 | 复发性输卵管透明细胞腺癌 | 复发性输卵管未分化癌 | 复发性卵巢透明细胞腺癌 | 复发性卵巢未分化癌 | 复发性铂类耐药输卵管癌 | 复发性铂类耐药原发性腹膜癌 | 复发性原发性腹膜透明细胞腺癌 | 复发性原发性腹膜未分化癌 | 铂类难治性输卵管癌 | 铂类难治性卵巢癌 | 铂类难治性原发性腹膜癌 | 复发性输卵管高级别浆液性腺癌 | 复发性卵巢浆液性癌 | 复发性原发性腹膜高级别浆液性腺癌 | 复发性卵巢癌肉瘤 | 复发性输卵管腺癌 | 复发性输卵管癌肉瘤 | 复发性高级别子宫内膜样腺癌 | 复发性卵巢腺癌 | 复发性原发性腹膜腺癌 | 复发性原发性腹膜癌肉瘤
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)尚未招聘
-
National Cancer Institute (NCI)NRG Oncology主动,不招人复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 卵巢浆液性癌 | 复发性铂耐药卵巢癌 | 原发性腹膜高级别浆液性腺癌 | 卵巢高级别浆液性腺癌 | 输卵管高级别浆液性腺癌 | 复发性输卵管透明细胞腺癌 | 复发性输卵管子宫内膜样腺癌 | 复发性输卵管未分化癌 | 复发性卵巢透明细胞腺癌 | 复发性卵巢子宫内膜样腺癌 | 复发性卵巢未分化癌 | 复发性铂类耐药输卵管癌 | 复发性铂类耐药原发性腹膜癌 | 复发性原发性腹膜透明细胞腺癌 | 复发性原发性腹膜子宫内膜样腺癌 | 复发性原发性腹膜未分化癌美国, 波多黎各
-
Shanghai Cell Therapy Group Co.,LtdShanghai Mengchao Cancer Hospital尚未招聘
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)邀请报名
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
GERCOR - Multidisciplinary Oncology Cooperative...Hoffmann-La Roche主动,不招人
-
Treatment Research InstituteNational Institute on Drug Abuse (NIDA); Robert J. Meyers PhD & Associates完全的
-
National Cancer Institute (NCI)完全的Trebananib 联合或不联合 Bevacizumab、Pazopanib Hydrochloride、Sorafenib Tosylate 或 Sunitinib Malate 治疗晚期肾癌患者晚期肾细胞癌 | III 期肾细胞癌 AJCC v7 | IV 期肾细胞癌 AJCC v7 | 晚期肉瘤样肾细胞癌美国
-
D'Or Institute for Research and EducationTERGOS PESQUISA E ENSINO S.A尚未招聘
-
Jiangsu Simcere Pharmaceutical Co., Ltd.未知
-
Virginia Commonwealth UniversityUnited States Department of Defense完全的
-
University of Maryland, BaltimoreUniversity of California, San Diego; Chestnut Health Systems主动,不招人
-
University of PennsylvaniaAmerican Heart Association完全的